SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-012539
Filing Date
2018-11-13
Accepted
2018-11-13 16:38:06
Documents
8
Period of Report
2018-11-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ENDRA LIFE SCIENCES INC. ndra_form8-k.htm 8-K 33193
2 UNDERWRITING AGREEMENT, DATED NOVEMBER 8, 2018 ndra_ex1-1.htm EX-1.1 176928
3 OPINION OF K&L GATES LLP ndra_ex5-1.htm EX-5.1 11956
4 PRESS RELEASE, DATED NOVEMBER 7, 2018 ndra_ex99-1.htm EX-99.1 14257
5 PRESS RELEASE, DATED NOVEMBER 8, 2018 ndra_ex99-2.htm EX-99.2 15429
6 PRESS RELEASE, DATED NOVEMBER 13, 2018 ndra_ex99-3.htm EX-99.3 16193
7 IMAGE logo.jpg GRAPHIC 1864
8 IMAGE ndra_logo.jpg GRAPHIC 6787
  Complete submission text file 0001654954-18-012539.txt   281414
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 181178545
SIC: 3845 Electromedical & Electrotherapeutic Apparatus